Page last updated: 2024-09-05

tesaglitazar and Kidney Diseases

tesaglitazar has been researched along with Kidney Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aguilar, E; Asghar, A; Ebenezer, P; Ferder, L; Francis, J; Hu, X; Isidro-Carrión, AA; Liao, J; Reisin, E; Soltani, Z; Zhang, R	1

Other Studies

1 other study(ies) available for tesaglitazar and Kidney Diseases

Article	Year
Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker rats. Nephron. Experimental nephrology, 2010, Volume: 114, Issue:2 Topics: Alkanesulfonates; Animals; Blood Pressure; Glomerular Filtration Rate; Kidney; Kidney Diseases; Metabolic Syndrome; Obesity; Phenylpropionates; PPAR alpha; PPAR gamma; Rats; Rats, Zucker	2010

Article

Year

Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker rats.

Nephron. Experimental nephrology, 2010, Volume: 114, Issue:2

Topics: Alkanesulfonates; Animals; Blood Pressure; Glomerular Filtration Rate; Kidney; Kidney Diseases; Metabolic Syndrome; Obesity; Phenylpropionates; PPAR alpha; PPAR gamma; Rats; Rats, Zucker

2010